[1] Schiltz R L, Mizzen C A, Vassilev A, et al. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J Biol Chem, 1999, 274(3) :11891192.
[2] Jensen K, Shiels C, Freemont P S. PML protein isoforms and the RBCC/TRIM motif. Oncogene, 2001, 20(49) :72237233.
[3] Beech S J, Lethbridge K J, Killick N, et al. Isoforms of the promyelocytic leukemia protein differ in their effects on ND10 organization. Exp Cell Res, 2005, 307(1) :109117.
[4] Everett R D, ChelbiAlix M K. PML and PML nuclear bodies: implications in antiviral defence. Biochimie, 2007, 89(67) :819830.
[5] Negorev D, Maul G G. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene, 2001, 20(49) :72347242.
[6] Zhong S, Muller S, Ronchetti S, et al. Role of SUMO1modified PML in nuclear body formation. Blood, 2000, 95(9) :27482752.
[7] Cho H, Orphanides G, Sun X, et al. A human RNA polymerase II complex containing factors that modify chromatin structure. Mol Cell Biol, 1998, 18(9) :53555363.
[8] Liu L, Scolnick D M, Trievel R C, et al. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol, 1999, 19(2) :12021209.
[9] Jin Y, Zeng S X, Dai M S, et al. MDM2 inhibits PCAF (p300/CREBbinding proteinassociated factor)mediated p53 acetylation. J Biol Chem, 2002, 277(34) :3083830843.
[10] Liu X, Tesfai J, Evrard Y A, et al. cMyc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation. J Biol Chem, 2003, 278(22) :2040520412.
[11] Masumi A, Wang I M, Lefebvre B, et al. The histone acetylase PCAF is a phorbolesterinducible coactivator of the IRF family that confers enhanced interferon responsiveness. Mol Cell Biol, 1999, 19(3) :18101820.
[12] Masumi A, Ozato K. Coactivator p300 acetylates the interferon regulatory factor2 in U937 cells following phorbol ester treatment. J Biol Chem, 2001, 276(24) :2097320980.
[13] Kurooka H, Honjo T. Functional interaction between the mouse notch1 intracellular region and histone acetyltransferases PCAF and GCN5. J Biol Chem, 2000, 275(22) :1721117220.
[14] Yao Y L, Yang W M, Seto E. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol, 2001, 21(17) :59795991.
[15] Doucas V, Tini M, Egan D A, et al. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc Natl Acad Sci U S A, 1999, 96(6) :26272632.
[16] Guo A, Salomoni P, Luo J, et al. The function of PML in p53dependent apoptosis. Nat Cell Biol, 2000, 2(10) :730736.
[17] Wei X, Yu Z K, Ramalingam A, et al. Physical and functional interactions between PML and MDM2. J Biol Chem, 2003, 278(31) :2928829297.
[18] Zhong S, Salomoni P, Pandolfi P P. The transcriptional role of PML and the nuclear body. Nat Cell Biol, 2000, 2(5) :8590.
[19] Boisvert F M, Kruhlak M J, Box A K, et al. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J Cell Biol, 2001, 152(5) :10991106.
[20] Hayakawa F, Abe A, Kitabayashi I, et al. Acetylation of PML is involved in histone deacetylase inhibitormediated apoptosis. J Biol Chem, 2008, 283(36) :2442024425. |